$370.70
0.67%
NYSE, Nov 18, 03:59 pm EST.
ISIN
US5049221055
Symbol
LH

Laboratory Corporation of America (LabCorp) Stock price

$370.78
+51.95 16.29% 1M
+115.21 45.08% 6M
+119.90 47.79% YTD
+110.97 42.71% 1Y
+159.68 75.64% 3Y
+123.81 50.13% 5Y
+262.54 242.54% 10Y
+311.61 526.60% 20Y
NYSE, Closing price Wed, Nov 18 2026
+2.54 0.69%
ISIN
US5049221055
Symbol
LH

AI Insights on Laboratory Corporation of America (LabCorp) Insights AI Insights on Laboratory Corporation of America (LabCorp)

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is Laboratory Corporation of America (LabCorp) a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,085 stocks worldwide.

Key metrics

Basic
Market capitalization
$30.1b
Enterprise Value
$35.8b
Net debt
$5.7b
Cash
$261.8m
Shares outstanding
81.2m
Valuation
P/E
30.1
P/S | estimate
2.1 | 2.0
EV/Sales | estimate
2.5 | 2.3
EV/FCF | ex SBC
27.8 | 30.8
P/B
3.4
Dividends
DPS
$2.88
Yield 1Y | 5Y
0.8% | 1.1%
Growth 1Y | 5Y
0.0% | -
Payout 1Y | 3Y
27.5% | 35.1%
Increased
0 Years
Financials
Revenue | estimate
$14.6b | $15.3b
EBITDA
$1.9b
EBIT
$1.6b
Net Income
$1.0b
Free Cash Flow | ex SBC
$1.3b | $1.2b
Growth
Revenue | estimate
6.0% | 9.5%
EBITDA
18.6%
EBIT
20.4%
Net Income
17.4%
Free Cash Flow
-6.8%
Margin
Gross
29.0%
EBITDA
13.4%
EBIT
11.3%
Net
6.9%
Free Cash Flow | ex SBC
8.8% | 8.0%
Financial Health
Equity Ratio
46.9%
Return on Equity
10.2%
ROCE
10.2%
ROIC
7.7%
Debt/Equity
0.7
Share-Based Compensation & Dilution
SBC | % of Revenue
$127.1m | 0.9%
SBC as % of FCF
9.9%
SBC Growth 1Y
3.0%
Share Count Growth 1Y
-2.2%
Shareholder Yield
2.9%
More
EPS
$12.3
FCF per Share
$15.8
Short interest
3.1%
Employees
66k
Rev per Employee
$210.0k

Laboratory Corporation of America (LabCorp) Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Laboratory Corporation of America (LabCorp) forecast:

21x Buy
78%
6x Hold
22%

Analyst Opinions

27 Analysts have issued a Laboratory Corporation of America (LabCorp) forecast:

Buy
78%
Hold
22%

Laboratory Corporation of America (LabCorp) Events

Past Events
NOV
10
2026 UBS Global Healthcare Conference
9 days ago
OCT
28
Q3 2026 Earnings Call
22 days ago
SEP
15
Morgan Stanley 24th Annual Global Healthcare Conference
2 months ago
SEP
10
Analyst/Investor Day - Labcorp Holdings Inc.
2 months ago
JUL
30
Q2 2026 Earnings Call
4 months ago
JUN
3
Jefferies Global Healthcare Conference 2026
6 months ago
APR
30
Q1 2026 Earnings Call
7 months ago
FEB
17
Q4 2025 Earnings Call
9 months ago
JAN
13
44th Annual J.P. Morgan Healthcare Conference
10 months ago
OCT
28
Q3 2025 Earnings Call
about one year ago

Financial data from Laboratory Corporation of America (LabCorp)

Sep '26
+/-
%
14,595 14,595
6% 6%
100%
- Direct Costs 10,367 10,367
5% 5%
71%
4,227 4,227
8% 8%
29%
- Selling and Administrative Expenses 2,278 2,278
0% 0%
16%
- Research and Development Expense - -
-
-
1,949 1,949
19% 19%
13%
- Depreciation and Amortization 305 305
10% 10%
2%
EBIT (Operating Income) EBIT 1,644 1,644
20% 20%
11%
Net Profit 1,004 1,004
17% 17%
7%

In millions USD.

Don't miss a Thing! We will send you all news about Laboratory Corporation of America (LabCorp) directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Laboratory Corporation of America (LabCorp) Stock News

Neutral
Market Watch
●
about 23 hours ago
Defensive sectors have beaten the S&P 500 by a wide margin in recent months, even though they are priced much higher relative to earnings estimates than the index.
Neutral
GlobeNewsWire
●
one day ago
DEERFIELD BEACH, Fla., Nov. 18, 2026 (GLOBE NEWSWIRE) -- OTraces, Inc., a diagnostics company developing proteomic blood tests for early cancer detection, today announced that it has selected Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, to perform reference laboratory testing for its Florida Department of Health–funded clinical trial evaluating the OT...
Neutral
PRNewsWire
●
one day ago
Expansion will bring clinical trial services closer to research sites and patients while supporting global studies BURLINGTON, N.C., Nov. 17, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced a collaboration with Grupo Fleury, one of Brazil's leading healthcare and diagnostic groups, with extensive laboratory infrastruc...
More Laboratory Corporation of America (LabCorp) News

Company Profile

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

Head office United States
CEO Mr. Schechter
Employees 66,385
Website www.labcorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today